Steroid inhalers for asthma or chronic obstructive pulmonary disease (COPD) may increase chances of bacterial infections in older adults, according to a large study published in the European Respiratory Journal.
Worldwide, asthma and COPD affect hundreds of thousands of people and they are commonly treated with steroid inhalers to reduce symptoms and improve lung function.
Asthma
It''s a lung condition characterized by inflammation of the bronchi and constriction of the airways that result in coughing, wheezing or breathlessness. Allergy and other airway irritants can trigger it
Advertisement
‘Steroid inhalers prescribed for asthma are found to increase the risk of lung infections caused by nontuberculous mycobacteria, which are notoriously difficult to treat and resistant to a number of common antibiotics.’
Tweet it Now
However, the new study suggests that these inhalers also increase the risk of lung infections caused by nontuberculous mycobacteria, which are notoriously difficult to treat and resistant to a number of common antibiotics.
Dr Sarah Brode, Assistant Professor of medicine at the University of Toronto, Canada and a staff respirologist at the University Health Network and West Park Healthcare, explained: "These infections are not particularly common but they are chronic and difficult to treat, and are associated with an increased risk of death. Treatment typically requires at least three antibiotics given for longer than a year and this can still fail to tackle the infection."
![Tests for Asthma]( "Tests for Asthma")
Do you find it difficult to breathe especially during the cold weather? You may need to get tested for asthma, a respiratory condition that is induced by allergies.
The study included 417,494 people with COPD or asthma aged 66 and older, who had all been prescribed medicine for their condition at least once.
Of these patients, researchers found that 2,966 had also been diagnosed with nontuberculous mycobacteria infections and they compared this information with whether they used a steroid inhaler, the type of steroid they had used, and how much they had used it.
They found that people who were currently using steroid inhalers were around twice as likely to be diagnosed with an infection of this type, and that the longer they had been taking the steroid, the greater the risk. They also discovered that one particular type of steroid, called fluticasone, was particularly risky.
Previous research has suggested that steroid inhalers hamper the body's ability to fight infections by reducing or impairing the cells of the immune system.
Dr Brode explained that steroid inhalers are critical treatments for managing asthma symptoms for most patients. Although they have also been shown to benefit patients with COPD, they are less important in the management of this condition, and they may only provide more benefit than harm in a sub-set of COPD patients. There is an ongoing debate on which patients with COPD should be treated with inhaled steroids.
This research suggests that patients should discuss whether they need to use steroid inhalers with their clinicians, and whether the benefits outweigh the potential harms. If they do need to use them, they should be on the lowest effective dose.
"Clinicians should carefully consider the potential benefits and harms of steroid inhalers in patients with asthma or COPD, especially those who have already had an infection of this type in the past."
Professor Guy Brusselle, Science Council Chair of the European Respiratory Society, said: "This is a large and important observational study on the effects of steroid inhalers in older people with asthma and COPD. Although not common, infections caused by nontuberculous mycobacteria are serious and difficult to treat. We must consider the effects of steroid inhalers on the risk of these infections alongside their known benefits and side-effects."
"Patients who are prescribed steroid inhalers should not stop their medicine. But, if they are concerned, they should speak to their doctor about the pros and cons of the treatment and whether it is right for them."
Source: Eurekalert
Tests for Asthma
Do you find it difficult to breathe especially during the cold weather? You may need to get tested for asthma, a respiratory condition that is induced by allergies.
Advertisement
The study included 417,494 people with COPD or asthma aged 66 and older, who had all been prescribed medicine for their condition at least once.
Of these patients, researchers found that 2,966 had also been diagnosed with nontuberculous mycobacteria infections and they compared this information with whether they used a steroid inhaler, the type of steroid they had used, and how much they had used it.
They found that people who were currently using steroid inhalers were around twice as likely to be diagnosed with an infection of this type, and that the longer they had been taking the steroid, the greater the risk. They also discovered that one particular type of steroid, called fluticasone, was particularly risky.
Previous research has suggested that steroid inhalers hamper the body's ability to fight infections by reducing or impairing the cells of the immune system.
Dr Brode explained that steroid inhalers are critical treatments for managing asthma symptoms for most patients. Although they have also been shown to benefit patients with COPD, they are less important in the management of this condition, and they may only provide more benefit than harm in a sub-set of COPD patients. There is an ongoing debate on which patients with COPD should be treated with inhaled steroids.
This research suggests that patients should discuss whether they need to use steroid inhalers with their clinicians, and whether the benefits outweigh the potential harms. If they do need to use them, they should be on the lowest effective dose.
"Clinicians should carefully consider the potential benefits and harms of steroid inhalers in patients with asthma or COPD, especially those who have already had an infection of this type in the past."
Professor Guy Brusselle, Science Council Chair of the European Respiratory Society, said: "This is a large and important observational study on the effects of steroid inhalers in older people with asthma and COPD. Although not common, infections caused by nontuberculous mycobacteria are serious and difficult to treat. We must consider the effects of steroid inhalers on the risk of these infections alongside their known benefits and side-effects."
"Patients who are prescribed steroid inhalers should not stop their medicine. But, if they are concerned, they should speak to their doctor about the pros and cons of the treatment and whether it is right for them."
Source: Eurekalert
Respiratory Diseases
Respiratory diseases affect any part of the respiratory system. Some of the lung diseases like chronic obstructive pulmonary disease can lead to respiratory failure.
Advertisement
 WheezingWheezing is a sound arising from the airways due to an obstruction or narrowing, which prevents the free flow of air. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.